| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000041209 |
| Receipt No. | R000047060 |
| Scientific Title | Retrospective study for brain tumor related epilepsy in metastatic brain tumor |
| Date of disclosure of the study information | 2020/07/26 |
| Last modified on | 2020/07/26 (Ver. 1) |
| Basic information | ||
| Public title | Retrospective study for brain tumor related epilepsy in metastatic brain tumor | |
| Acronym | Brain tumor related epilepsy in metastatic brain tumor | |
| Scientific Title | Retrospective study for brain tumor related epilepsy in metastatic brain tumor | |
| Scientific Title:Acronym | BTRE-R | |
| Region |
|
|
| Condition | ||
| Condition | Brain tumor related epilepsy in metastatic brain tumor | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | All patients who had experience of brain tumor related epilepsy (BTRE) due to metastatic brain tumors are registered, and our project pick up risk factors of BTRE. Our final object is to make plan for the prospective clinical trial of prophylactic administration of ant-epileptic drugs(AED). |
| Basic objectives2 | Others |
| Basic objectives -Others | Retrospective study |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | initial epileptic attack |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | metastatic brain tumor patients due to systematic cancer | |||
| Key exclusion criteria | CSF dissemination without cerebral parenchymal metastasis | |||
| Target sample size | 600 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hirosaki University Graduate School of Medicine | ||||||
| Division name | Department of Neurosurgery | ||||||
| Zip code | 036-8562 | ||||||
| Address | Zaifu-Cho 5, Hirosaki-Shi, Aomori Prefecture, 036-8562, Japan | ||||||
| TEL | 0172-39-5115 | ||||||
| asanoken@hirosaki-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hirosaki University Graduate School of Medicine | ||||||
| Division name | Department of Neurosurgery | ||||||
| Zip code | 036-8562 | ||||||
| Address | Zaifu-Cho 5, Hirosaki-Shi, Aomori Prefecture, 036-8562, Japan | ||||||
| TEL | 0172-39-5115 | ||||||
| Homepage URL | |||||||
| asanoken@hirosaki-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Neurosurgery, Hirosaki University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Neurosurgery, Hirosaki University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Committee of Medical Ethics of Hirosaki University Graduate School of Medicine,Hirosaki,Japan |
| Address | Zaifu-Cho 5, Hirosaki-Shi, Aomori Prefecture, 036-8562, Japan |
| Tel | 0172-33-5111 |
| jm5194@hirosaki-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 606 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | N/A |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047060 |